SRx Health Solutions, Inc. (SRXH): Nasdaq/NYSE listing notice — Better Choice receives NYSE American delisting notice for equity non-compliance

SRx Health Solutions, Inc.

Received NYSE American notice dated Apr 24, 2024 for non-compliance with Sections 1003(a)(ii) and (iii).
Stockholders' equity was $3.0M vs required $4M or $6M, with losses in 3 of 4 recent fiscal years.
Must submit compliance plan by May 24, 2024; deadline to regain compliance is Oct 24, 2025.
Stock to trade with '.BC' designation; no immediate impact on listing.
If plan not accepted or compliance not achieved, will face delisting procedures.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

SRx Health Solutions, Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).

Exchange: nyse american
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 1003(a)(ii), 1003(a)(iii)

Exact text from the filing

April 24, 2024, notifying the Company that it is no longer in compliance with NYSE American continued listing standards. Specifically, the letter states that the Company is not in compliance with the continued listing standards set forth in Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide (the “Company Guide”). Section 1003(a)(ii) requires a listed company to have stockholders’ equity of $4 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. Section 1003(a)(iii) requires a

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

SRx Health Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-017088

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.